Provided by Tiger Trade Technology Pte. Ltd.

ResMed

221.15
+0.05000.02%
Post-market: 221.150.00000.00%19:30 EDT
Volume:930.42K
Turnover:206.71M
Market Cap:31.90B
PE:21.20
High:224.14
Open:220.75
Low:219.00
Close:221.10
52wk High:284.87
52wk Low:180.27
Shares:144.25M
Float Shares:143.49M
Volume Ratio:0.99
T/O Rate:0.65%
Dividend:2.40
Dividend Rate:1.09%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:4.84
PE(LYR):21.20

Loading ...

Resmed Shares Down 8.7% Premarket After Q4 Results

THOMSON REUTERS
·
Aug 07

Stock Track | ResMed Plunges 8.78% in 24-Hour Trading as Revenue Growth Deceleration Overshadows Q4 Earnings Beat

Stock Track
·
Aug 07

Movement Alert|ResMed Falls 8.41% in Pre-Market Trading, Earnings Beat Expectations but Revenue Growth Deceleration Sparks Concern

Market Focus
·
Aug 07

Resmed Inc. : RBC Raises Target Price to $244 from $234

THOMSON REUTERS
·
Aug 07

Resmed Inc. : Piper Sandler Cuts Target Price to $225 from $233

THOMSON REUTERS
·
Aug 07

Stock Track | ResMed Plunges 6.07% in 24-Hour Trading as Revenue Growth Deceleration Overshadows Q4 Earnings Beat

Stock Track
·
Aug 07

Movement Alert|ResMed Declines 6.15% Overnight, Earnings Beat but Revenue Growth Slowdown Sparks Concerns

Market Focus
·
Aug 07

Deferral of Conversions Between Australian and US Registers-RMD.N

Reuters
·
Aug 07

144 Report of Proposed Sale of Securities-RMD.N

Reuters
·
Aug 07

Resmed Q4 FY2026 Earnings: Revenue Rises as Safety Costs Weigh on GAAP Margins

TradingKey
·
Aug 07

ResMed Fiscal Q4 Non-GAAP Earnings, Revenue Up

MT Newswires Live
·
Aug 07

ResMed Raises Quarterly Dividend, Reports Higher 4Q Revenue, Profit

Dow Jones
·
Aug 07

ResMed Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

ResMed Posts Fiscal Q4 Non-GAAP EPS of $2.95, Revenue of $1.46 Billion

MT Newswires Live
·
Aug 07

Stock Track | ResMed Plunges 6.83% in After-Hours Trading as Revenue Growth Deceleration Overshadows Q4 Earnings Beat

Stock Track
·
Aug 07

Movement Alert|ResMed Falls 5.03% in After-Hours Trading, Earnings Beat but Growth Deceleration Raises Concerns

Market Focus
·
Aug 07

ResMed Q4 FY26 GAAP Diluted EPS Rises 2% to $2.64; Revenue Increases 9% to $1.46 Billion

Reuters
·
Aug 07

Resmed Q4 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Aug 07

Resmed Q4 Adjusted EPS USD 2.95 Vs. IBES Estimate USD 2.89

Reuters
·
Aug 07

ResMed Q4 Adj. EPS $2.95 Beats $2.89 Estimate, Sales $1.464B Beat $1.459B Estimate

Benzinga Earnings
·
Aug 07